Male Infertility: Causes, Diagnosis, and Treatment Options

1. Introduction: The Overlooked Half of Infertility

When couples struggle to conceive, the focus often defaults to the female partner. This assumption is both outdated and inaccurate. Male factor infertility is present in 40-50% of all infertility cases, and in approximately 20-30% of couples, it is the sole identified cause. Despite these statistics, male fertility evaluation is frequently delayed or overlooked entirely until months or even years into the fertility journey.

The World Health Organization (WHO) estimates that approximately 1 in 20 men worldwide have some form of fertility impairment. This number has been rising — a landmark 2022 meta-analysis published in Human Reproduction Update found that global sperm counts have declined by more than 50% over the past five decades, from an average of 101 million/mL in 1973 to 49 million/mL in 2018. While the causes of this decline are multifactorial (environmental toxins, lifestyle changes, delayed parenthood), the trend underscores the importance of comprehensive male fertility assessment.

The encouraging news is that male infertility is often highly treatable. Advances in diagnostic testing can now identify the root cause in the majority of cases, and treatments ranging from lifestyle modifications and medications to advanced reproductive technologies like ICSI (Intracytoplasmic Sperm Injection) have made biological fatherhood possible for men who would have been considered irreversibly infertile just a generation ago.

2. Common Causes of Male Infertility

Male fertility depends on a complex interplay of hormonal signals, testicular function, and the physical structures that transport sperm. Disruption at any point in this chain can impair fertility. Understanding the underlying cause is essential for directing treatment appropriately.

3. Semen Analysis Explained: Normal Parameters

The semen analysis is the cornerstone of male fertility evaluation. It provides a quantitative and qualitative assessment of sperm production and function. The World Health Organization (WHO) publishes reference values based on data from fertile men in multiple countries. The current WHO 6th Edition (2021) guidelines represent the 5th percentile of a fertile population — meaning 95% of men who fathered a child within 12 months had values above these thresholds.

Understanding Abnormal Results

Abnormalities in semen analysis are classified using standardized terminology:

• Oligozoospermia — Sperm concentration below 16 million/mL. Mild (10-16 million/mL), moderate (5-10 million/mL), severe (under 5 million/mL).
• Asthenozoospermia — Reduced sperm motility (progressive motility under 30%).
• Teratozoospermia — Reduced normal morphology (under 4% by strict criteria).
• Azoospermia — Complete absence of sperm in the ejaculate. Affects approximately 1% of all men and 10-15% of infertile men. Can be obstructive (sperm produced but blocked) or non-obstructive (impaired production).
• Oligoasthenoteratozoospermia (OAT) — All three parameters (count, motility, morphology) are below normal. This is the most common pattern in male infertility.
• Necrozoospermia — A high percentage of dead sperm, which may indicate epididymal pathology, infection, or prolonged abstinence.

4. Advanced Diagnostic Tests

While a standard semen analysis provides essential baseline information, advanced testing can reveal abnormalities that are invisible under a standard microscope. These tests are particularly important when semen analysis results are borderline, when there is unexplained infertility despite normal parameters, or when there have been recurrent pregnancy losses or failed IVF cycles.

Sperm DNA Fragmentation Testing

Sperm DNA fragmentation (SDF) measures the percentage of sperm with damaged or broken DNA strands. Even sperm with normal count, motility, and morphology can carry significant DNA damage, which has been linked to:

• Reduced fertilization rates in both natural conception and IVF
• Poor embryo development and lower blastocyst formation rates
• Increased miscarriage risk — studies show a 2-4 fold increase in miscarriage when SDF exceeds 30%
• Recurrent IVF/ICSI failure — unexplained failed cycles despite good embryo quality

Several testing methods exist: SCSA (Sperm Chromatin Structure Assay), TUNEL assay, COMET assay, and SCD (Sperm Chromatin Dispersion) test. A DNA fragmentation index (DFI) below 15% is considered excellent, 15-25% is fair, 25-30% is borderline, and above 30% is associated with significantly reduced fertility outcomes.

Hormonal Panel

A comprehensive male hormonal evaluation typically includes:

• FSH (Follicle-Stimulating Hormone) — Elevated FSH indicates impaired sperm production (testicular failure). Normal or low FSH with low testosterone suggests a pituitary or hypothalamic problem.
• LH (Luteinizing Hormone) — Drives testosterone production by Leydig cells. The LH:testosterone ratio helps localize the problem.
• Total and Free Testosterone — Low levels impair libido and can affect sperm production.
• Prolactin — Elevated prolactin (hyperprolactinemia) suppresses GnRH, reducing FSH/LH and impairing sperm production.
• Estradiol (E2) — Elevated estradiol in men can suppress the HPG axis, often seen in obesity due to aromatization of testosterone in adipose tissue.
• Inhibin B — Produced by Sertoli cells; a direct marker of sperm production. Low inhibin B correlates with poor spermatogenesis and is useful for predicting surgical sperm retrieval success.

Genetic Testing

Genetic testing is indicated for men with severe oligozoospermia (under 5 million/mL) or azoospermia:

• Karyotype — Identifies chromosomal abnormalities such as Klinefelter syndrome (47,XXY), which is found in approximately 10% of azoospermic men.
• Y Chromosome Microdeletion Testing — Detects deletions in the AZF (Azoospermia Factor) regions. AZFc deletions are the most common; complete AZFa or AZFb deletions carry a very poor prognosis for sperm retrieval.
• CFTR Gene Testing — Screens for cystic fibrosis transmembrane conductance regulator mutations in men with congenital bilateral absence of the vas deferens (CBAVD).

Scrotal and Transrectal Ultrasound

Imaging studies help identify structural abnormalities:

• Scrotal ultrasound with Doppler — Detects varicoceles (especially subclinical ones not palpable on exam), testicular tumors, and testicular atrophy.
• Transrectal ultrasound (TRUS) — Evaluates the prostate, seminal vesicles, and ejaculatory ducts for obstruction, cysts, or calcifications in cases of low-volume azoospermia.

5. Lifestyle Factors That Affect Sperm Quality

One of the most empowering aspects of male fertility is that many factors affecting sperm quality are modifiable. Because a complete spermatogenesis cycle takes approximately 64-74 days, lifestyle changes implemented consistently for 3 months can produce measurable improvements in semen parameters. The evidence supporting these interventions is increasingly robust.

Smoking

Cigarette smoke contains over 4,000 chemicals, many of which are known reproductive toxicants. A 2023 meta-analysis of 30 studies involving over 20,000 men found that smokers had, on average, 23% lower sperm concentration, 13% lower motility, and significantly higher DNA fragmentation rates compared to non-smokers. The good news: sperm quality begins to improve within 3 months of smoking cessation, and DNA fragmentation levels can return to normal ranges.

Alcohol

Chronic heavy alcohol consumption (over 14 drinks per week) is associated with reduced testosterone production, testicular atrophy, and impaired sperm production. A 2022 Danish study of 1,200 men found that even moderate alcohol intake (5-10 drinks per week) was associated with a 33% reduction in sperm concentration. The mechanism involves direct testicular toxicity and disruption of the HPG axis. Complete abstinence or strict moderation is recommended for men trying to conceive.

Heat Exposure

The testes are located outside the body for a reason: optimal sperm production requires a temperature 2-4°C below core body temperature. Chronic heat exposure is a well-established cause of impaired spermatogenesis. Sources include:

• Hot baths, saunas, and hot tubs — regular use (over 2-3 times per week) can reduce sperm count by 30-50%
• Laptop computers on the lap — can raise scrotal temperature by 2-3°C within 60 minutes
• Tight underwear and clothing — traps heat and raises testicular temperature
• Prolonged sitting — occupations requiring long hours of sitting (truck drivers, desk workers) are associated with higher scrotal temperatures and reduced sperm quality
• Fever — even a single febrile illness can temporarily suppress sperm production for 2-3 months

Switching to loose-fitting boxer shorts, avoiding hot baths and saunas, and taking regular standing breaks can produce measurable improvements in sperm parameters within 3 months.

Exercise and Body Weight

Obesity is independently associated with reduced sperm quality. Adipose tissue converts testosterone to estradiol via the aromatase enzyme, creating a hormonal environment unfavorable for sperm production. A 2023 meta-analysis found that overweight and obese men have 24-30% lower sperm concentrations and significantly higher DNA fragmentation rates. Weight loss of 5-10% of body weight has been shown to improve both hormonal profiles and semen parameters.

Moderate exercise is beneficial, but excessive endurance training (marathon running, elite cycling) can paradoxically impair sperm quality through heat exposure, mechanical trauma, oxidative stress, and hormonal disruption. The sweet spot appears to be 150-300 minutes of moderate-intensity exercise per week.

Stress and Sleep

Chronic psychological stress elevates cortisol, which suppresses testosterone production and can impair sperm quality. A 2022 study found that men in the highest quartile of perceived stress had 38% lower sperm concentration and 20% lower motility compared to those in the lowest quartile. Sleep quality matters too: men who sleep less than 6 hours or more than 9 hours per night have been shown to have reduced sperm counts. Aim for 7-8 hours of quality sleep per night.

6. Diet and Supplements for Male Fertility

Nutrition plays a fundamental role in sperm health. Sperm are highly susceptible to oxidative stress because their cell membranes are rich in polyunsaturated fatty acids, which are easily damaged by reactive oxygen species (ROS). A diet rich in antioxidants, healthy fats, and essential micronutrients provides the building blocks for healthy sperm and protects against oxidative damage.

The Mediterranean Diet for Sperm Health

Multiple studies have demonstrated that adherence to a Mediterranean-style diet is associated with significantly better semen parameters. A 2023 systematic review of 10 studies found that men with the highest Mediterranean diet adherence scores had 15-25% higher sperm concentration, better motility, and lower DNA fragmentation compared to those with the lowest adherence. Key components include:

• Abundant fruits and vegetables — rich in antioxidants including vitamin C, vitamin E, beta-carotene, and polyphenols
• Fatty fish (2-3 servings/week) — provides omega-3 fatty acids (DHA/EPA) essential for sperm membrane fluidity
• Nuts and seeds — walnuts, almonds, flaxseeds, and pumpkin seeds provide zinc, selenium, and healthy fats
• Whole grains and legumes — complex carbohydrates with fiber that stabilize blood sugar and insulin
• Extra virgin olive oil — monounsaturated fats and polyphenols with anti-inflammatory properties
• Limited red meat and processed foods — reduce intake of pro-inflammatory saturated and trans fats

Key Supplements for Male Fertility

Targeted supplementation can address specific nutritional deficiencies and provide concentrated doses of nutrients that support sperm production and protect against oxidative damage.

7. Treatment Options for Male Infertility

Treatment for male infertility follows a tiered approach, progressing from the least invasive interventions to advanced assisted reproductive technologies. The specific treatment pathway depends on the identified cause, severity of sperm abnormalities, female partner's age and fertility status, and the couple's preferences and timeline.

Surgical Sperm Retrieval

For men with obstructive or non-obstructive azoospermia, sperm can be surgically retrieved directly from the testis or epididymis for use in ICSI:

• TESA (Testicular Sperm Aspiration) — A needle is inserted into the testis to aspirate sperm. Minimally invasive, suitable for obstructive azoospermia.
• TESE (Testicular Sperm Extraction) — A small open biopsy removes testicular tissue. Higher yield than TESA.
• Micro-TESE — Using an operating microscope, the surgeon identifies and extracts the most productive seminiferous tubules. The gold standard for non-obstructive azoospermia, with sperm retrieval rates of 40-60% depending on the underlying cause.
• PESA (Percutaneous Epididymal Sperm Aspiration) — A needle aspirates sperm from the epididymis. Suitable for obstructive azoospermia with normal sperm production.
• MESA (Microsurgical Epididymal Sperm Aspiration) — Microscopic surgical retrieval from the epididymis, yielding the highest quality and quantity of sperm in obstructive cases.

8. When to Consider ICSI IVF

ICSI (Intracytoplasmic Sperm Injection) has transformed the treatment of male infertility. Unlike conventional IVF, where thousands of sperm are placed with each egg and fertilization occurs naturally, ICSI involves the direct injection of a single, carefully selected sperm into the cytoplasm of each mature egg. This technique bypasses all the natural barriers to fertilization and requires only one viable sperm per egg.

Clear Indications for ICSI

ICSI is not automatically required for all IVF cycles. It is specifically indicated in the following situations:

• Severe oligozoospermia — Sperm concentration consistently below 5 million/mL, or total motile sperm count below 1 million after processing, where conventional IVF fertilization rates drop significantly.
• Severe asthenozoospermia — Progressive motility below 10-15%, where sperm cannot penetrate the egg's outer layers independently.
• Severe teratozoospermia — Normal morphology below 1-2% (by strict Kruger criteria), particularly when globozoospermia (round-headed sperm lacking acrosomes) is present.
• Obstructive azoospermia — Surgically retrieved sperm from the epididymis (PESA/MESA) or testis (TESA/TESE) typically have reduced motility and must be used with ICSI.
• Non-obstructive azoospermia — Sperm retrieved via micro-TESE are immature and require ICSI. These sperm may not have completed full cytoplasmic maturation, but can still achieve fertilization and live birth.
• High sperm DNA fragmentation (DFI > 25-30%) — ICSI allows selection of individual sperm with lower DNA damage. Advanced sperm selection techniques (PICSI, MACS, IMSI) can further reduce the chance of selecting sperm with fragmented DNA.
• Previous failed fertilization with conventional IVF — If a prior IVF cycle resulted in complete or near-complete fertilization failure (under 20-30% of eggs fertilized) despite apparently normal sperm parameters.
• Preimplantation genetic testing (PGT) — ICSI is mandatory when PGT is planned, as conventional IVF can leave residual cumulus cells and sperm DNA on the zona pellucida, contaminating the genetic sample.
• Use of frozen-thawed sperm with compromised post-thaw quality — Cryopreserved sperm from cancer patients, donor sperm with marginal parameters, or sperm retrieved and frozen before vasectomy.
• Unexplained infertility with long duration — Some clinics recommend ICSI for couples with over 3-4 years of unexplained infertility, as subtle sperm dysfunction may not be detected by standard semen analysis.

ICSI Success Rates

ICSI achieves a fertilization rate of 70-80% of mature (MII) eggs — comparable to or higher than conventional IVF in non-male factor cases. Importantly, fertilization rates with ICSI are largely independent of sperm quality. Even with severely compromised sperm parameters, as long as a viable sperm can be identified and injected, normal fertilization is possible.

Live birth rates after ICSI depend primarily on female age and embryo quality, not on the severity of the male factor. For women under 35, the live birth rate per ICSI embryo transfer is approximately 45-55% with a single blastocyst transfer. With multiple embryos available for frozen transfer, cumulative live birth rates after one egg retrieval approach 60-70%.

Advanced Sperm Selection for ICSI

When standard ICSI is performed, the embryologist selects sperm based on morphology and motility under 400x magnification. However, several advanced techniques can improve sperm selection, particularly when DNA fragmentation is elevated:

• PICSI (Physiological ICSI) — Sperm are placed on a plate coated with hyaluronic acid, which mimics the egg's outer coating. Mature sperm with lower DNA fragmentation bind to the hyaluronic acid, allowing selection of higher-quality sperm.
• IMSI (Intracytoplasmic Morphologically Selected Sperm Injection) — Uses ultra-high magnification (over 6000x) to examine sperm morphology in minute detail, identifying subtle structural abnormalities invisible at standard magnification.
• MACS (Magnetic-Activated Cell Sorting) — Uses magnetic beads to separate apoptotic (programmed for cell death) sperm from healthy sperm, reducing the chance of selecting sperm with fragmented DNA.
• Microfluidic sperm sorting — A newer technology that mimics the natural selection that occurs in the female reproductive tract, selecting sperm based on their ability to swim through micro-channels. Early data shows lower DNA fragmentation in selected sperm compared to standard density gradient centrifugation.

9. Frequently Asked Questions